These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13206487)

  • 1. Carbohydrate metabolism in brain disease. I. Glucose metabolism in multiple sclerosis.
    HENNEMAN DH; ALTSCHULE MD; GONCZ RM; ALEXANDER L
    AMA Arch Neurol Psychiatry; 1954 Dec; 72(6):688-95. PubMed ID: 13206487
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose metabolism in multiple sclerosis.
    CERKEZ C; CHANDLER JH; CHANDLER D
    Dis Nerv Syst; 1962 Jul; 23():377-82. PubMed ID: 13877712
    [No Abstract]   [Full Text] [Related]  

  • 3. Carbohydrate metabolism and nutritional state in multiple sclerosis.
    DROLLER H; POWELL IJ
    J Chronic Dis; 1956 Sep; 4(3):283-91. PubMed ID: 13357613
    [No Abstract]   [Full Text] [Related]  

  • 4. OBSERVATIONS ON CEREBRAL CARBOHYDRATE METABOLISM IN MAN.
    SCHEINBERG P
    Ann Intern Med; 1965 Feb; 62():367-71. PubMed ID: 14259220
    [No Abstract]   [Full Text] [Related]  

  • 5. [The question of carbohydrate metabolism disorder in multiple sclerosis; with special reference to cocarboxylase therapy].
    GROS H; KIRNBERGER EJ; SCHIFFER KH
    Munch Med Wochenschr; 1955 Feb; 97(5):130-2. PubMed ID: 14356117
    [No Abstract]   [Full Text] [Related]  

  • 6. Carbohydrate metabolism in brain disease. II. Glucose metabolism in Schizophrenic, manic-depressive, and involutional psychoses.
    HENNEMAN DH; ALTSCHULE MD; GONCZ RM
    AMA Arch Intern Med; 1954 Sep; 94(3):402-16. PubMed ID: 13196721
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipid chemistry of the brain in demyelinating diseases.
    CUMINGS JN
    Brain; 1955; 78(4):554-63. PubMed ID: 13293269
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbohydrate and lipid metabolism in multiple sclerosis: Clinical implications for etiology, pathogenesis, diagnosis, prognosis, and therapy.
    Pashaei S; Mohammadi P; Yarani R; Haghgoo SM; Emami Aleagha MS
    Arch Biochem Biophys; 2021 Nov; 712():109030. PubMed ID: 34517010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The brain structures functional activity and aggression patients' multiple sclerosis].
    Reznikova TN; Seliverstova NA; Kataeva GV; Aroev RA; Il'ves AG; Kuznetsova AK
    Fiziol Cheloveka; 2015; 41(1):35-42. PubMed ID: 25857175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THE ASSOCIATION OF AMYOTROPHIC LATERAL SCLEROSIS (MOTOR NEURON DISEASE) AND CARBOHYDRATE INTOLERANCE, A CLINICAL STUDY.
    STEINKE J; TYLER HR
    Metabolism; 1964 Nov; 13():1376-81. PubMed ID: 14241228
    [No Abstract]   [Full Text] [Related]  

  • 11. Brain lipids in multiple sclerosis and other diseases.
    GERSTL B; KAHNKE MJ; SMITH JK; TAVASTSTJERNA MG; HAYMAN RB
    Brain; 1961 Jun; 84():310-9. PubMed ID: 13704767
    [No Abstract]   [Full Text] [Related]  

  • 12. PET imaging of glucose metabolism, neuroinflammation and demyelination in the lysolecithin rat model for multiple sclerosis.
    de Paula Faria D; de Vries EF; Sijbesma JW; Buchpiguel CA; Dierckx RA; Copray SC
    Mult Scler; 2014 Oct; 20(11):1443-52. PubMed ID: 24622349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral metabolism of glutamic acid in multiple sclerosis.
    ADAMS JE; HARPER HA; GORDAN GS; HUTCHIN M; BENTINCK RC
    Neurology; 1955 Feb; 5(2):100-7. PubMed ID: 13235985
    [No Abstract]   [Full Text] [Related]  

  • 14. Myelin lipids in multiple sclerosis.
    EDGAR GW
    Acta Neurol Psychiatr Belg; 1959 Jun; 59():756-61. PubMed ID: 13819294
    [No Abstract]   [Full Text] [Related]  

  • 15. [PHOSPHORUS DEFICIENCY AND MULTIPLE SCLEROSIS. A HYPOTHESIS ON THE ETIOLOGY AND PATHOGENESIS OF THE DISEASE].
    BERGENGREN H
    Sven Lakartidn; 1964 Nov; 61():3516-51. PubMed ID: 14238375
    [No Abstract]   [Full Text] [Related]  

  • 16. Histochemical studies of active carbonyl groups (Proteolipids) in brains with multiple sclerosis.
    ASHBEL R; ALEXANDER L; RASKIN N
    J Neuropathol Exp Neurol; 1953 Jul; 12(3):293-301. PubMed ID: 13061977
    [No Abstract]   [Full Text] [Related]  

  • 17. The cerebral lipids in multiple sclerosis (interim communication).
    PLUM CM; HANSEN SE
    Acta Psychiatr Scand Suppl; 1960; 35(141):84-92. PubMed ID: 14433537
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of inhibitors on the metabolism of specifically labelled glucose by brain.
    HOSKIN FC
    Biochim Biophys Acta; 1960 May; 40():309-13. PubMed ID: 14403298
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple sclerosis.
    Newman JP
    N Engl J Med; 2001 Feb; 344(5):381-2. PubMed ID: 11195797
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucose uptake heterogeneity of the leg muscles is similar between patients with multiple sclerosis and healthy controls during walking.
    Kindred JH; Ketelhut NB; Rudroff T
    Clin Biomech (Bristol, Avon); 2015 Feb; 30(2):159-65. PubMed ID: 25541392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.